A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA

<strong>Background:</strong> The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak. <strong>Methods:</strong> In this phase 1 study,...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Ewer (nee Russell), K, Rampling, T, Venkatraman, N, Bowyer, G, Wright, D, Lambe, T, Imoukhuede, E, Payne, R, Fehling, S, Strecker, T, Biedenkopf, N, Krähling, V, Tully, C, Edwards, N, Bentley, E, Samuel, D, Labbe, G, Jin, J, Gibani, M, Minhinnick, A, Wilkie, M, Poulton, I, Lella, N, Roberts, R, Hartnell, F, Bliss, C, Sierra-Davidson, K, Powlson, J, Berrie, E, Tedder, R, Roman, F, Ryck, I, Nicosia, A, Sullivan, N, Stanley, D, Mbaya, O, Ledgerwood, J, Schwartz, R, Siani, L, Colloca, S, Folgori, A, Di Marco, S, Cortese, R, Wright, E, Becker, S, Graham, B, Koup, R, Levine, M, Volkmann, A, Chaplin, P, Pollard, A, Draper, S, Ballou, W, Lawrie, A, Gilbert, S, Hill, A
Format:	Journal article
Wydane:	Massachusetts Medical Society 2016

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA

Podobne zapisy